An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers

BRCA1/2 germline mutation related cancers are candidates for new immune therapeutic interventions. This study was a hypothesis generating exploration of genomic data collected at diagnosis for 19 patients.